AN2 Therapeutics, Inc.【ANTX】Balance sheet

Market cap

$141.52M

P/E ratio

	2022/12	2023/12	2024/12
Cash and cash equivalents	27	16	21
Marketable securities, current	69	92	62
Total cash & short-term investments	96	107	84
Total current assets	99	111	86
Marketable securities, non-current	3	27	5
Total non-current assets	4	28	6
Total assets	103	139	92
Accounts payable	2	3	3
Total current liabilities	7	14	-
Total non-current liabilities	0	-	-
Total liabilities	7	14	10
Common stock and paid-in capital	185	279	288
Retained earnings	-90	-154	-206
Stockholders' equity	95	125	82